Resultados de la búsqueda 11-20 of 2845 for ������������KA���:ZA31���24������ ���������������������������������

  1. Mayo Clinic Physician Update - December 2024

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  7. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia - Mayo Clinic

    Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia · Tu donación es muy poderosa... ¿quieres ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  9. Mayo Clinic Cardiovascular Physician Update - March 2025

    Page 1.

  10. Mayo Clinic Ophthalmology Physician Update - December 2024

    Page 1.